-
2022-501608-85-00
5
2023-05-09
Cardiovascular disease (atherosclerotic cardiovascular disease (ASCVD)
-
2023-506924-94-00
5
2023-02-28
Cardiovascular disease
-
2023-505552-22-00
5
2023-02-24
Stage I-III Triple-negative Breast Cancer with residual invasive disea
-
2022-501304-10-00
6
2023-02-06
In-hospital cardiac arrest
-
2023-504027-78-00
4
2023-01-13
Previously Untreated Locally Advanced or Metastatic Urothelial Cancer
-
2023-504741-32-00
4
2022-11-30
Moderately to Severely Active Crohn's Disease
-
2023-504743-13-00
4
2022-11-30
Moderately to Severely Active Ulcerative Colitis
-
2023-506361-56-00
5
2022-04-01
Endometrial cancer
-
2023-506771-10-00
5
2022-03-11
Breast Neoplasm, Neoplasm Metastasis
-
2023-503772-24-00
10
2021-09-15
IgA Nephropathy
-
2022-502122-41-00
5
2021-05-11
Clear cell renal cancer
-
2024-514287-84-00
5
2021-04-28
Multiple sclerosis
-
2023-505835-11-00
5
2021-03-12
Chronic Migraine
-
2023-505836-36-00
5
2021-03-12
Migraine
-
2023-509405-77-00
5
2021-02-16
Colorectal cancer (BRAF V600E-mutant mCRC)
-
2023-505936-37-00
6
2021-02-03
Urothelial cancer
-
2024-515404-39-00
5
2021-01-14
Breast cancer
-
2023-506911-16-00
5
2020-12-04
ESTROGEN RECEPTOR-POSITIVE, HER2-NEGATIVE LOCALLY ADVANCED OR METASTAT
-
2023-505852-23-00
5
2020-11-12
High risk recurrent prostate cancer previously treated with radical pr
-
2024-514733-38-00
5
2020-11-03
Unresectable locally-advanced or metastatic HER2+ breast cancer
-
2024-518173-34-00
9
2020-06-02
Borderline resectable, locally advanced or metastatic pancreatic cance
-
2023-508292-37-00
5
2020-03-06
Cardiovascular Disease
-
2022-501973-37-00
5
2020-01-30
Endometrial cancer
-
2023-506551-23-00
5
2019-11-21
Recurrent or primary advanced (Stage III or IV) endometrial cancer